2016 Meeting Archives

Presentation Slides - February 24, 2016

Post-Graduate Course: Advances in the Science and Practice in Tuberculosis Control

The Spectrum of Ideas about TB Latency
Dr. David R. Sherman, Seattle Biomedical Research Institute, Seattle, WA, USA

Latent TB: Simplifying the Clinical Approach to a Complex Biologic Disease
Dr. Robert Belknap, Denver Health, Denver, CO, USA

Microbiome Approaches for TB: NTM Diagnostics
Dr. Rebecca Davidson, National Jewish Health, Denver, CO, USA

Whole Genome Next Generation Sequencing of TB in a Public Health Laboratory: A New Diagnostic Era
Dr. Kimberlee Musser, New York State Department of Health, Albany, NY, USA

Short Case Presentation & Impact of Effective Treatment on Transmission and Transcriptomics on Captured Aerosol
Dr. Edward Nardell, Harvard School of Public Health, Boston, MA, USA

Treatment Rapidly Alters the Physiologic State of M. tuberculosis in Sputum
Dr. Nick Walter, Denver VA Medical Center, Denver, CO, USA

Preventing Transmission of TB: Research and Reality
Dr. Kevin Fennelly, National Institutes of Health, Bethesda, MD, USA

Presentation Slides - February 25, 2016

Stop TB Meeting: Global and Regional Challenges in TB Elimination

Progress, Challenges Toward the Goal of Global TB Elimination
Dr. Knut Lönnroth, World Health Organization, Geneva, Switzerland
Watch the video here

Epidemiological Modelling of TB Elimination
Dr. David Dowdy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Watch the video here

TB Elimination in Canada: Can We Get There?
Dr. Richard Long, University of Alberta, Edmonton, AB, Canada

TB Elimination: "California Dreamin"
Drs. Pennan Barry and Jennifer Flood, California Department of Public Health, Richmond, CA, USA

TB Elimination in the Caribbean: The Suriname Experience
Dr. Eric Commiesie, Ministry of Health, Paramaribo, Suriname

PAHO’s Pilot TB Program: Framework of TB Control in Large Cities
Dr. Mirtha del Granado, PAHO, Washington, DC, USA

The Beyond TB Lecture - One Health: Beyond Medicine
Dr. Francisco J. Olea-Popelka, The Union, Paris, France

The George Comstock Lecture - Global Scale-Up of the Management of Drug-Resistant Tuberculosis: Why is This So Hard?
Dr. Charles Daley, National Jewish Health, Denver, CO, USA

Nursing Sponsored Session - TB Elimination through Collaborative Partnerships

Paramedics: Responding to More than Shootings and Heart Attacks
Mr. Mike Taigman and Ms. Eva Reeder, American Medical Response, Ventura County Public Health, Ventura, CA, USA

3 P’s: Pharmacist, Pills, and PPDs (Part 1 - Diana Fortune)
3 P’s: Pharmacist, Pills, and PPDs (Part 2 - Mai Vu)
Presented by Ms. Deborah Isaacks on behalf of Ms. Diana Fortune
Ms. Mai Vu, San Francisco VA Medical Center, San Francisco, CA, USA

College Entrance: SAT, ACT and Now a TST and IGRA too? (Part 1 - Teresa Wortmann)
College Entrance: SAT, ACT and Now a TST and IGRA too? (Part 2 - Phil Griffin)
Ms. Teresa Wortmann, Missouri Department of Health and Senior Services, Jefferson City, MO, USA
Mr. Phil Griffin, Kansas Tuberculosis Control Program, Topeka, KS, US

Presentation Slides - February 26, 2016

Current Issues on Pediatric TB

The Epidemiology, Clinical Characteristics and Outcomes of Pediatric Central Nervous System Tuberculosis in California from 1993-2011; A Search for Modifiable Clinical and Epidemiological Risk Factors
Dr. Alexander Kay, California Department of Public Health, Richmond, CA, USA

Treatment Outcomes of Childhood Tuberculous Meningitis: A Systematic Review of TB Meningitis
Dr. Silvia Chiang, Baylor College of Medicine, Houston, TX, USA

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents
Dr. Jeffrey Starke, Baylor Medical Center, Houston, TX, USA

School Outbreaks and Exposures: Best Practices and Management
Mr. Phil Griffin, Kansas Department of Health, Topeka, KS, USA

TB Genomics in Clinical and Public Health Practice

Introduction to the TB Genome
Dr. James Johnston, BC Centre for Disease Control, Vancouver, BC, Canada

The Impact of Genomics Era on Mycobacterium tuberculosis Research
Dr. James Posey, Center for Disease Control, Atlanta, GA, USA

Implementing WGS as Clinical Decision Making Tool
Dr. Shaheed Vally Omar, South African National Institute for Communicable Disease, Cape Town, South Africa

Tracking TB in the Canadian North: Detecting Outbreaks among Founder Strains
Dr. Robyn Lee, McGill University, Montreal, QC, Canada

Reconstructing TB Outbreaks with Genomics: Lessons from an Outbreak in BC Homeless Shelter
Dr. Jennifer Gardy, BC Centre for Disease Control, Vancouver, BC, Canada

Presentation Slides - February 27, 2016

Public Health is Local: One Size Doesn't Fit All

Overview of the Unaccompanied Children with TB
Dr. John Jereb, Office of Refugee Resettlement, Washington, DC, USA

Texas Interfaith Welcome Coalition: Personal Perspectives
Ms. Catalina Navarro, Heartland National TB Center, San Antonio, TX, USA

Homelessness, Housing, and Tuberculosis: The National Picture
Dr. Sapna Morris, Centers for Disease Control and Prevention, Atlanta, GA, USA

The Local Picture: Atlanta, Georgia
Dr. Susan Ray, Emory University, Atlanta, GA, USA

The Local Picture: Seattle King County, Washington
Dr. Masa Narita, Public Health Seattle, Seattle, WA, USA

HUD: National Program with Housing Solutions
Mr. David Canavan, HUD, Washington, DC, USA

Drug Resistant Session

Low Level Rifampin Resistance: Diagnostic Challenges and Treatment Outcomes
Dr. Neha Shah, Centers for Disease Control and Prevention, Atlanta, GA, USA

Impact of the Number of Drugs, Treatment Duration and PZA on MDR TB Treatment Outcomes
Dr. Carole Mitnick, Partners in Health, Harvard University, Boston, MA, USA

Successful Use of Repurposed Drugs for MDR TB: Meropenem/Clavulanate and its Newer Relatives
Dr. Maunank Shah, Johns Hopkins University, Baltimore, MD, USA

Page Last Updated: 23/06/2020